Literature DB >> 8011235

Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire.

W Janssens1, L Heyndrickx, Y Van de Peer, A Bouckaert, K Fransen, J Motte, G M Gershy-Damet, M Peeters, P Piot, G van der Groen.   

Abstract

OBJECTIVES: To examine the genetic variation of HIV-1 isolates in Abidjan, Côte d'Ivoire, and to determine the extent to which phylogenetic trees based on sequence information of part of the env gene containing the principal neutralizing domain are representative for documenting genetic variability.
DESIGN: Phylogenetic comparison of 13 HIV-1 strains isolated from patients in Abidjan with previously documented HIV-1 strains of different geographic origin.
METHODS: To sequence a 900 base-pair fragment of the env gene containing V3, V4, V5 and the beginning of gp41 of three to four clones per isolate. Phylogenetic tree analysis was performed with the software package TREECON.
RESULTS: Eleven HIV-1 isolates of Abidjan were classified as genotype A, while two were classed as genotypes B and D. Intra-genotype A distances at the nucleotide level were a maximum of 14.1%. Inter-genotype distances between genotype A and genotypes B, C, and D varied from 16.0 to 22.6%. Phylogenetic trees, based on sequence data of a 300 base-pair fragment containing the V3 loop, showed significant differences in tree topology and statistical confidence with phylogenetic trees based on sequence data of the 900 base-pair env fragment.
CONCLUSIONS: Genotype A Côte d'Ivoire HIV-1 strains, which comprise 11 out of 13 isolates, predominate in Abidjan, which may indicate a local burst of particular variants. Phylogenetic trees should be interpreted with caution when based on a more limited number of nucleotides, such as the V3 region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011235     DOI: 10.1097/00002030-199401000-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.

Authors:  L Heyndrickx; W Janssens; L Zekeng; R Musonda; S Anagonou; G Van der Auwera; S Coppens; K Vereecken; K De Witte; R Van Rampelbergh; M Kahindo; L Morison; F E McCutchan; J K Carr; J Albert; M Essex; J Goudsmit; B Asjö; M Salminen; A Buvé; G van Der Groen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Relative reactivity of the V3 loop PND of HIV-1 subtypes A, B, C, D, and F with sera from selected Ugandan localities.

Authors:  J P Riley; G A Pestano; K Hosford; C Francis; J M Xie; P Mugyenyi; P Kataaha; E Katongole-Mbidde; W W Anokbonggo; J Guyden
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Authors:  F Gao; S G Morrison; D L Robertson; C L Thornton; S Craig; G Karlsson; J Sodroski; M Morgado; B Galvao-Castro; H von Briesen; S Beddows; J Weber; P M Sharp; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Multivariate analysis of human immunodeficiency virus type 1 neutralization data.

Authors:  P N Nyambi; J Nkengasong; P Lewi; K Andries; W Janssens; K Fransen; L Heyndrickx; P Piot; G van der Groen
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.

Authors:  L G Kostrikis; Y Cao; H Ngai; J P Moore; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data.

Authors:  Nathalie Boutonnet; Wouter Janssens; Carlo Boutton; Jean-Luc Verschelde; Leo Heyndrickx; Els Beirnaert; Guido van der Groen; Ignace Lasters
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 7.  HIV preventive vaccines. Progress to date.

Authors:  J Esparza; S Osmanov; W L Heyward
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

8.  Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I.

Authors:  L G Kostrikis; E Bagdades; Y Cao; L Zhang; D Dimitriou; D D Ho
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Pattern of the evolution of HIV-1 enν gene in Côte d׳Ivoire.

Authors:  Sery Gonedelé Bi; Didier P Sokouri; Kouakou Tiékoura; Oulo Alla NNan; Marcel Lolo; Félix Gnangbé; Assanvo Sp NGuetta
Journal:  Bioinformation       Date:  2014-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.